Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Jingzhou Hou is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Hou is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Rafic Farah is an Oncologist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Farah is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Anastasios Raptis is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Raptis is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

John Lister is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Lister is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Cyrus Khan is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Khan is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed Refractory Multiple Myeloma (RRMM), Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.

Mounzer Agha is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Agha is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Agha is currently accepting new patients.

Salman Fazal is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Fazal is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelofibrosis, Aplastic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Santhosh Sadashiv is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Sadashiv is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Anna Koget is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Koget is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health. Dr. Ito is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Steven Fein, MD, specializes in hematology oncology and is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Hematology Oncology. Dr. Fein completed his fellowship at University of Miami Miller School of Medicine at Jackson Memorial Hospital, residency at Duke University Medical Center, and medical education at Johns Hopkins University School of Medicine. Dr. Fein is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Yazan Samhouri is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Samhouri is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Plasmacytoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Orchiectomy, and Bone Marrow Aspiration.

Vincent Edgar Reyes, Jr., MD, is the chief medical officer of the UPMC Hillman Cancer Center Medical Oncology Network and assistant clinical professor of medicine at the University of Pittsburgh School of Medicine. Dr. Reyes is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Paget Disease of the Breast.

Robert VanderWeele, MD, MS, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in cytopenias, bleeding and clotting disorders, leukemia, lymphoma, myeloma, GI malignancies, breast cancer, lung cancer, and prostate cancer. Dr. Vanderweele is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.